Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Volume Plasma Exchange in Pediatric Acute Liver Failure
NCT02719210Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Jan 2016
- Primary completion
- Nov 2018
- Countries
- 1
01
Overview
Randomised, open-label trial in acute liver failure (ALF) (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Transplant free Survival at 30 days. Started Jan 2016; status: completed.
02
Conditions
acute liver failure (ALF)
Beyond the preview
Go deeper on NCT02719210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02719210.